(c) 2024 PillSync.com

24 HR darifenacin 15 MG Extended Release Oral Tablet Enablex

1 INDICATIONS AND USAGE Enablex (darifenacin) is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency. Enablex is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency ( 1 )

Warner Chilcott (US), LLC


5 years ago ROUND ORANGE DF 15 24 HR darifenacin 15 MG Extended Release Oral Tablet Enablex

ROUND ORANGE DF 15

5 years ago ROUND ORANGE DF 15 24 HR darifenacin 15 MG Extended Release Oral Tablet Enablex

DF 15 ROUND ORANGE

16 HOW SUPPLIED/STORAGE AND HANDLING Enablex ® , 7.5 mg are round, shallow, bi-convex, white-colored tablets, and are identified with “DF” on one side and “7.5” on the reverse. Bottle of 30........................................................................ NDC 0430-0170-15 Bottle of 90........................................................................ NDC 0430-0170-23 Enablex ® , 15 mg are round, shallow, bi-convex, light peach-colored tablets, and are identified with “DF” on one side and “15” on the reverse. Bottle of 30........................................................................ NDC 0430-0171-15 Bottle of 90........................................................................ NDC 0430-0171-23 Storage Store at 25° C (77° F); excursions permitted to 15 to 30° C (59 to 86° F) [see USP Controlled Room Temperature]. Protect from light. Keep this and all drugs out of the reach of children.


More pills like ROUND DF 15












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site